Biologics for wounds, Cell & Gene Therapy
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
201
NCT05608187
Evaluating Safety and Biological Effect on Wound Healing of ILP100-Topical in Subjects With Diabetic Foot Ulcers
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 26, 2022
Completion: Dec 20, 2024
NCT06401499
The Effect of Pregabalin and Etoricoxib on Pain Alone Versus in Combination
Phase: Phase 4
Start: Jun 1, 2024
Completion: Dec 31, 2024
NCT06410365
Impact of Intrathecal vs Intravenous Dexmedetomidine
Loading map...